Accelerated FDA approval for dostarlimab in biomarker-defined locally advanced rectal cancer
The FDA granted accelerated approval for dostarlimab in adults with stage II or III locally advanced rectal cancer whose tumors ...
The FDA granted accelerated approval for dostarlimab in adults with stage II or III locally advanced rectal cancer whose tumors ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine